1 completed, 1 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
Follow Calcific Uremic Arteriolopathy: new trials by email Literature Review of Calcific Uremic Arteriolopathy trials Research Report on Calcific Uremic Arteriolopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study of SNF472 for Calciphylaxis Experimental: SNF472, Placebo Comparator: Placebo, Experimatenl SNF472 (Open-label) - Calciphylaxis, Calcific Uremic Arteriolopathy | Phase 3 | Completed | Sanifit Therapeutics S. A. | 71 | 2020-02-12 | 2024-02-20 |
| Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Sodium thiosulfate, Placebo - Calciphylaxis, Calcific Uremic Arteriolopathy | Phase 3 | Withdrawn | American Regent, Inc. | 2015-01-30 | 2025-05-07 |
Calciphylaxis (2) · Kidney Failure, Chronic (1) · Wounds and Injuries (1)
Calcinosis (2) · Calcium Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Urogenital Diseases (1)
Sodium Chloride (1) · sodium thiosulfate (1)
American Regent, Inc. (1) · Sanifit Therapeutics S. A. (1)
United States (2) · Belgium (1) · Germany (1) · Poland (1) · Spain (1) · United Kingdom (1)
Alex Gold, MD (1) · Linda Mundy, MD, PhD (1)